Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Autolus Therapeutics (AUTL) Shares Outstanding: 2018-2024

Historic Shares Outstanding for Autolus Therapeutics (AUTL) over the last 6 years, with Dec 2024 value amounting to $34,425.

  • Autolus Therapeutics' Shares Outstanding changed negligibly% to $34,425 in Q4 2024 from the same period last year, while for Dec 2024 it was $34,425, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $34,425 for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q4 2024, Autolus Therapeutics' Shares Outstanding stood at $34,425, which was down 0.00% from $34,425 recorded in Q4 2023.
  • Over the past 5 years, Autolus Therapeutics' Shares Outstanding peaked at $173.9 billion during Q3 2023, and registered a low of $34,425 during Q4 2023.
  • Over the past 2 years, Autolus Therapeutics' median Shares Outstanding value was $34,425 (recorded in 2024), while the average stood at $34,425.
  • Within the past 5 years, the most significant YoY rise in Autolus Therapeutics' Shares Outstanding was 91.05% (2023), while the steepest drop was 100.00% (2023).
  • Quarterly analysis of 3 years shows Autolus Therapeutics' Shares Outstanding stood at $122.5 million in 2021, then reached $34,425 in 2023, then remained steady at $34,425 in 2024.
  • Its Shares Outstanding was $34,425 in Q4 2024, compared to $34,425 in Q4 2023 and $173.9 billion in Q3 2023.